Advisor Group, Inc. - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 65 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2017. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.

Quarter-by-quarter ownership
Advisor Group, Inc. ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q4 2019$28,000
+154.5%
2,400
+20.0%
0.00%
Q3 2019$11,000
-54.2%
2,0000.0%0.00%
Q2 2019$24,000
+140.0%
2,0000.0%0.00%
Q1 2019$10,000
+66.7%
2,0000.0%0.00%
Q4 2018$6,000
-50.0%
2,0000.0%0.00%
Q3 2018$12,000
+9.1%
2,0000.0%0.00%
Q2 2018$11,000
-8.3%
2,0000.0%0.00%
Q1 2018$12,000
+71.4%
2,0000.0%0.00%
Q4 2017$7,0000.0%2,0000.0%0.00%
Q3 2017$7,000
+40.0%
2,0000.0%0.00%
Q2 2017$5,000
+400.0%
2,000
+300.0%
0.00%
Q1 2017$1,0005000.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q4 2017
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 919,000$4,816,0002.29%
RTW INVESTMENTS, LP 6,256,840$32,786,0002.24%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 480,000$2,515,0001.08%
Bpifrance SA 828,262$4,340,0000.49%
WS MANAGEMENT LLLP 888,722$4,657,0000.28%
Eventide Asset Management 1,146,580$6,008,0000.21%
683 Capital Management, LLC 362,386$1,899,0000.17%
Orbimed Advisors 1,243,200$6,514,0000.10%
Sofinnova Investments, Inc. 159,237$835,0000.08%
Rhenman & Partners Asset Management AB 119,673$627,0000.07%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders